相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pretargeting: taking an alternate route for localizing radionuclides
Robert M. Sharkey et al.
TUMOR BIOLOGY (2012)
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide
Eric Frampas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging
Kelly Davis Orcutt et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
A modular IgG-scFv bispecific antibody topology
Kelly Davis Orcutt et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-Ig™) molecules
Chengbin Wu et al.
MABS (2009)
A strategy for bacterial production of a soluble functional human neonatal Fc receptor
Jan Terje Andersen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein
Paul J. Yazaki et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
DM Goldenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Humanization of the anti-CEA T84.66 antibody based on crystal structure data
PJ Yazaki et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
Advances in pretargeting biotechnology
DA Goodwin et al.
BIOTECHNOLOGY ADVANCES (2001)